Showing results (181-190 of 339) with videos related to

Sort By:
Pageof 34
Vaccine|February 6, 2018
Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature reviewFiona M Guerra, Natasha S Crowcroft, Lindsay Friedman, et al.
Human Vaccines & Immunotherapeutics|June 22, 2017
Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparisonArun Kumar, Janet E McElhaney, Lisa Walrond, et al.
The Journal of Pediatrics|November 15, 2003
Predictors of death in infants hospitalized with pertussis: a case-control study of 16 pertussis deaths in CanadaLynda K Mikelova, Scott A Halperin, David Scheifele, et al.
Eclinicalmedicine|October 8, 2021
Effectiveness and cost-effectiveness of RSV infant and maternal immunization programs: A case study of Nunavik, CanadaShokoofeh Nourbakhsh, Affan Shoukat, Kevin Zhang, et al.
Pediatrics|August 19, 2016
Hospitalization for Influenza A Versus BDat Tran, Wendy Vaudry, Dorothy Moore, et al.
Cellular Immunology|July 19, 2016
Respiratory macrophages regulate CD4 T memory responses to mucosal immunization with recombinant adenovirus-based vaccinesElizabeth Acosta-Ramirez, Cynthia Tram, Rachel M Kampen, et al.
Vaccine|March 7, 2006
Interchangeability of two diphtheria and tetanus toxoids, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b conjugate vaccines as a fourth dose in 15-20-month-old toddlersScott A Halperin, Bruce Tapiero, Barbara Law, et al.
Obstetrics and Gynecology|March 5, 2016
Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine: A Randomized Controlled TrialGilbert G G Donders, Scott A Halperin, Roland Devlieger, et al.
The Pediatric Infectious Disease Journal|October 18, 2011
The hidden costs and characteristics of childhood rotavirus emergency visits in CanadaNicole Le Saux, Julie Bettinger, Pierre Déry, et al.
Vaccine|October 15, 2010
Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of ageScott A Halperin, Anil Gupta, Robert Jeanfreau, et al.
Pageof 34